Goodwin represented Base Therapeutics on the matter. Base Therapeutics announced the out-licensing of its proprietary base editing technology on a non-exclusive basis to a leading international biopharmaceutical…
Base Therapeutics’ Out-Licensing its Proprietary Base Editing Technology
